
Innovate Carolina’s Office of Technology Commercialization (OTC) supports university research based startups, helping translate innovations across biotechnology, medical devices, gene therapy, digital health, and more into real‑world impact. This directory highlights UNC‑affiliated companies leveraging cutting‑edge discoveries to address critical challenges in health, science, and technology.
Categories:
Exited
908 Devices (IPO)
908 Devices is bringing the powerful capabilities of mass spectrometry out of the confines of centralized laboratories. 908 Devices’ products range from rugged, handheld chemical detection tools to compact, dedicated analyzers for researchers, serving a range of industries including safety …
Advanced Chemotherapy Technologies (acquired by Focal Medical/Continuity Biosciences)
Advanced Chemotherapy Technologies (ACT) is developing an implantable device to infuse chemotherapy drugs directly into the pancreas, targeting difficult-to-reach tumors while largely sparing surrounding tissues, organs and blood vessels. The device, about the size of a quarter, would be implanted …
Asklêpios BioPharmaceutical, Inc. (“AskBio”) (acquired by Bayer)
AskBio is advancing AAV gene therapy technologies developed in the Gene Therapy Center at UNC-CH. They have proprietary programs related to AAV capsid development, scaled-up manufacturing, and multiple therapeutic programs in the areas of neuromuscular, CNS and heart diseases.
Couragen (acquired by Belief Biomed)
Couragen is developing AAV vector platform Capsidex® offering tissue-specific gene delivery fortreatment of genetic diseases.
Dualogics (acquired by Abcellera Biologics)
At Dualogics, our vision is to use the latest advancements in protein engineering to create improved antibody therapies. We collaborate globally to bring our technologies and expertise to drug discovery campaigns across all therapeutic areas. Dualogics display uses combinatorial screening …
Enci Therapeutics (acquired by Innova Therapeutics)
Enci Therapeutics Inc is developing a humanized monoclonal antibody to block angiogenesis pathways dependent on the activity of SFRP2. This antibody may be used in combination with chemotherapy and Avastin for treatment of Avastin resistant metastatic breast cancer.
Epizyme Inc. (acquired by Ipsen after IPO)
Epizyme is a clinical stage epigenetics company that is developing small molecule inhibitors of histone methyltransferases for multiple oncology indications.
G1 Therapeutics (IPO)
G1 Therapeutics is a clinical-stage pharmaceutical company developing small-molecule therapeutic agents to protect patient bone marrow and the immune system from chemotherapy-induced damage.
KindHeart, Inc. (acquired by Intuitive Surgical)
KindHeart is a medical-simulation company specializing in surgery simulation systems that use real animal tissue, fully animated surgical simulators.
Liquidia Technologies (IPO)
Liquidia Technologies develops precision engineered drug particles that have the potential to dramatically improve the performance of medicines. The ability to modify nanoparticle attributes allows Liquidia to develop more optimized safe and effective vaccines and therapies for a wide variety of medical applications.
Meryx, Inc. (acquired by Xcovery)
Meryx is a biotechnology company developing inhibitors of Mer Receptor Tyrosine Kinase for the treatment of hematologic and solid tumors including leukemia, lung cancer and melanoma.
Novan, Inc. (acquired by Pelthos Therapeutics after IPO)
Novan, Inc. is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases.
Pulvinar Neuro (acquired by EPI)
Pulvinar Neuro provides cutting-edge neurotechnology to brain researchers. The company develops and markets a portable device for non-invasive brain stimulation research. Their solution uses transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS) for brain stimulation. Founder: Flavio …
SonoVol (acquired by Revitty [Perkin Elmer])
SonoVol is a life science research tools company, committed to making user-friendly products that accelerate disease research and drug development. Founders: Ryan Gessner, Paul Dayton
Startups
Accunovo Biotechnologies
Accunovo focuses on improvements in early cancer diagnosis. The Company is developing novel targeted PET imaging probes through a combination of unique biomarker-binding molecules and PET imaging molecules for targeted imaging of cancer, allowing earlier diagnosis and treatment. Founder: Rihe …
Advanced Cochlear Diagnostics
Advanced Cochlear Diagnostics is a leader in cochlear implant mapping. Its technology, now in use by AdvancedBionics, allows for real time intraoperative feedback on hearing estimation and implant placement..
Altis Biosystems
Altis Biosystems has developed a patent-pending human stem cell platform, which recreates both small and large intestinal tissue for drug screening and microbiome research for pharmaceutical and biotechnology companies. Altis’ technology is high-throughput and produces reproducible results to meet the …
AnelleO
AnelleO is harnessing the advancements in the speed and scale of 3D printing technology for novel solutions in Women’s Health. Intravaginal Rings (IVR) offer a unique platform for sustained delivery of therapeutics – a non-invasive, self-administered and retrievable platform that …
Arcato Laboratories Inc.
Arcato Laboratories Inc. is an oral health company developing ARC-001, a proprietary formulation of 3 non-opiod anesthetics which are administeered directly to the dental socket for extended pain relief after dental surgery.
Bedrock Therapeutics
Bedrock is an AAV research and development company working on both platform technologies and therapeutic cassettes for diverse genetic diseases. Founders: Matt Hirsch, Chengwen Li, Brian Gilger, Brian Sutton
Beyond Silicon, Inc.
Beyond Silicon, Inc. is breaking the limits of solar energy with tandem solar cell technology. By stacking perovskites on top of traditional silicon cells, the company’s platform makes more efficient use of the full solar spectrum. This next-generation solar technology is designed to achieve panel efficiencies exceeding 30%, lowering the cost of electricity and strengthening U.S. leadership in solar manufacturing.
BioClassifier
BioClassifier has developed in-vitro diagnostic and research products for breast cancer intrinsic subtyping based on the Bioclassifier PAM50 gene signature, now sold by Veracyte as Prosigna®.
Biospatial, Inc.
Biospatial, Inc. is transforming healthcare and emergency services by applying proprietary analytics and artificial intelligence to complex datasets. The company’s platform combines and analyzes electronic patient care reports from thousands of Emergency Medical Services (EMS) providers to generate actionable, real-time insights. This data empowers public health agencies and healthcare organizations to track trends, improve outcomes, and enhance community safety.
BlueSky Polymers
BlueSky Polymers is developing new chemistries for high-performance polymer material for 3D printing that can be used in both injection molding and composite materials for major industries, including aerospace, automotive, and oil and gas. Founders: Ed Samulski, Theo Dingemans
Capio Biosciences, Inc.
Capio Biosciences, Inc. is developing oncology diagnostics to improve patient care decisions through its CapioCyte™ liquid biopsy platform. This technology achieves superior sensitivity in capturing and isolating circulating tumor cells (CTCs) from whole blood. By enabling detailed post-capture molecular analysis, CapioCyte™ provides a powerful tool for cancer research and future clinical patient management.
Carolina Instruments
Carolina Instruments develops wearable, camera-free optical and physiological sensing devices that empower neuroscience researchers and clinicians to gain real-time insights into brain function, behavior, and cognitive states. Their innovative eye-tracking technology enables scalable, precise diagnostics for conditions like autism, ADHD, and Parkinson’s, while opening new possibilities in clinical, research, and human-performance applications.
Cell Microsystems, Inc.
Cell Microsystems develops cell separation and isolation tools. The CellRaftTM technology permits rapid and efficient separation and isolation of single cells.
ChemoGLO
ChemoGLO develops technologies that detect and remove chemotherapy drug contamination in hospitals, pharmacies, and laboratories through its ChemoGLO Wipe Kit and the Hazardous Drug Clean (HDClean) towelette cleaning system.
Cervu
Cervu is developing an intravaginal pelvic floor physical therapy device designed to help female cancer survivors manage chronic pelvic pain and dyspareunia resulting from cancer treatments. Founded by Dr. Alan Rosenbaum and Abby Scheer, Cervu’s patient-centered technology offers a comfortable, at-home solution to restore pelvic and sexual health and improve quality of life.
CNS Therapy
CNS Therapy, AG is creating a new paradigm for pain management by developing intelligent healthcare devices to manage chronic pain. The company’s technology tracks physiological parameters and uses this data to optimize and deliver personalized electrostimulation and behavioral therapy. This integrated approach empowers patients with chronic pain to reduce or eliminate their symptoms and restore their quality of life.
Codetta Bio
Codetta Bio is advancing and expanding life science research and diagnostic capabilities by providing streamlined, easy-to-use, multiomic, highly multiplexed digital assay solutions. Codetta Bio will set a new standard of multiomic performance and simplicity, enabling customers to gain greater insight …
Counter Tools
Counter Tools is a not-for-profit business that provides training, software tools, and technical assistance to public health and disease-prevention organizations.
Couplet Care
Couplet Care, LLC offers tools for improving patient safety and clinical efficiency, while promoting positive mother and infant health outcomes. Our first product, a postnatal unit medical infant bassinet, is a University of North Carolina spin-out, 510(k) Exempt, Class II …
Cortical Metrics
Cortical Metrics develops quantitative, noninvasive measures of brain health that can address a broad spectrum of neurological disorders.
dGenThera
dGenThera is advancing a next-generation radiotherapeutics platform using astatine-211 and iodine-131 to deliver brain-penetrant small molecules that selectively destroy cancer cells while sparing healthy tissue. By combining precision-targeted delivery with scalable, cost-effective production, dGenThera’s “Radiotherapeutics 2.0” approach offers improved safety, efficacy, and accessibility for treating aggressive cancers like glioblastoma, triple-negative breast cancer, and pancreatic cancer.
DelAQUA Pharmaceuticals
DelAQUA is a specialty pharma that has developed a breakthrough drug formulation technology that (a) reformulates marketed drugs to make them safer and more active and (b) formulates insoluble and unstable new chemical entities to make them safe and bioavailable. …
Delgen Biosciences
Delgen Biosciences strives to develop next-generation drug delivery technologies. To this goal, we are working to commercialize a novel polymer platform technology in creating better-in-class ophthalmic drugs and in the broader pharmaceutical space. The novel polymers designed and synthesized using …
Eldec Pharmaceuticals
Eldec Pharmaceuticals has developed a novel, first-in-class, broad-spectrum, lung-specific immunomodulator called ELD607. ELD607 beneficially normalizes lung neutrophil levels in five different murine lung disease models. By preventing lung-damaging neutrophilia, ELD607 reduces lung damage and increases survival outcomes. In bacterial pneumonia …
EnFuego Therapeutics
A biotech company developing novel RNA interference-(RNAi)-based and antisense oligo therapeutics for “non-druggable” oncogenes such as KRAS. The team has developed therapies that potently bind to mutant KRAS sequences while sparing wild-type KRAS and is optimizing different delivery platforms including …
Entegrion
Entegrion develops biological and medical-device technologies to enhance the safety and availability of the human blood supply. Entegrion has developed a lyophilized blood substitute product which is far more stable than stored human platelets and effective at stopping bleeding.
Epicypher
EpiCypher develops and manufactures novel tools and reagents for epigenetics drug development and chromatin biology research.
Epigenos Bioscience
Epigenos Biosciences is focused on developing dCas9 Chemical Epigenetic Modifiers (CEM) -based therapies for multiple rare diseases and cancers driven by single gene mis-regulation (i.e., a gene that is inappropriately turned on or off). Epigenos is developing therapies which combine …
Equiti Foods (formally GoodBowls)
Equiti Foods is a mission-driven venture focused on food access. Our flagship product line, Good Bowls, is a healthy frozen meal line based on the Mediterranean Diet and adapted for Southern taste preferences. The company is rooted in founder Dr. …
Fastback Bio, LLC
Fastback Bio, LLC is engineering a new generation of CAR-T therapeutics with its co-stimulatory domain platform, M83. This technology creates CAR-T cells with enhanced expansion kinetics, a balance of effector and memory phenotypes, and greater resistance to T-cell exhaustion. In preclinical models, M83-based CAR-T cells have demonstrated superior tumor-killing capabilities in solid tumors compared to current approaches.
ForagR Medicines, Inc.
ForagR Medicines is revolutionizing RNA-targeted drug discovery by using in-cell RNA genomics to develop small molecules that modulate undruggable proteins via their mRNAs. This platform overcomes longstanding challenges in RNA medicine, offering a faster, more precise path to therapeutics for cancer, neurological disorders, and other complex diseases.
GeneCentric Therapeutics
GeneCentric Therapeutics’ proprietary platform utilizes tumor genomic information to enable oncologists and their patients to make informed decisions through clinical trial design, prediction of drug response, drug development target selection and improved therapeutic results.
GeneVentiv Therapeutics
GeneVentiv Therapeutics is a preclinical gene therapy company developing GENV-HEM for Hemophilia A and B, designed to restore normal clotting without thrombosis—even in patients with inhibitors—and GENV-002, a gene editing therapy for Pompe disease that enables lifelong enzyme production for both infantile and late-onset forms. Their universal, one-time treatments aim to address unmet needs in severe inherited disorders.
Glycan Therapeutics
Glycan Therapeutics possesses a unique patented technology to synthesize heparin and heparan sulfate oligosaccharides for medical uses. The company is developing new drug therapies based on this novel synthetic carbohydrate technology platform. The platform technology can be used to synthesize …
Glyco Discoveries
Glyco Discoveries is a subsidiary of Glycan Therapeutics which develops and commercializes synthetic glycosaminoglycan products using proprietary chemoenzymatic technology to support research, diagnostics, and therapeutic innovation. Based in Raleigh, NC, the company enables precise, animal-free manufacturing of heparan and chondroitin sulfate molecules for applications in glycobiology and biopharmaceutical development.
Goldie Health, Inc.
Goldie Health offers a life-saving digital platform that enhances overdose detection, engagement, and care coordination for individuals at risk of opioid use disorder. By integrating with emergency medical records and social services, Goldie empowers Post Overdose Response Teams to intervene during the critical 72-hour “golden window,” significantly increasing patient identification and access to treatment.
IMMvention Therapeutix
IMMvention Therapeutix, based in Durham, NC, is focused on improving the lives of patients with auto-inflammatory diseases of huge unmet needs (such as Osteoarthritis, Gout, Inflammatory Bowel Disease, Alzheimer’s etc.). The company is discovering and developing first-in-class novel disease modifying …
Inhalon Biopharma
Inhalon Biopharma is a clinical-stage immunotherapy company with an inhaled muco-trapping antibody platform to prevent and treat acute respiratory infections. The platform enables inhaled antibodies to trap pathogens in airway mucus, thereby preventing the spread of infection. Trapped pathogens are …
InoKare Therapeutics
Inokare Therapeutics is developing small molecule inhibitors that target the novel enzyme IP6K1 to selectively reduce fat without affecting muscle mass. Leveraging a new mechanism of action, Inokare’s platform offers a promising therapeutic approach for metabolic disorders with improved safety, efficacy, and scalability compared to traditional treatments.
LED Radiofluidics
LED Radiofluidics, Corp. provides the imaging field easy access to cutting edge photoredox labeling technology. One arm of the company will develop simple and low-cost units that could be easily integrated into a commercial box to interface with existing cyclotrons …
MaiaZura
MaiaZura is a digital health company that builds immersive, trauma-informed virtual reality experiences to train healthcare professionals in compassionate, culturally responsive care. By combining evidence-based design with cutting-edge VR technology, MaiaZura enhances clinical empathy, communication, and decision-making in high-stakes and emotionally complex scenarios.
Mizar Imaging
Mizar Imaging is a modular light sheet illumination system designed for high-resolution imaging. Mounting to most inverted microscopes, the Tilt enables light sheet imaging to be easily added to an existing or new microscope system. Founder: Paul Maddox
Mizar Therapeutics
Mizar Therapeutics is a platform therapeutics company using proprietary live-cell single-molecule imaging and machine-learning technology for discovery of a new class of targeted cancer therapies. Founders: Paul Maddox, Joel Smith
Mucommune
Mucommune is a privately held company seeking to advance “muco-trapping” monoclonal antibodies for use in reinforcing female reproductive health. The technology is based on engineering the Fc region of IgG antibodies to interact with mucins which enables antibodies to immobilize …
NabGen
NabGen Inc. is a NC-based biotech company that is removing barriers to gene delivery and human health. Their platform technology functions as a universal antibody suppressant to inhibit anti-drug antibodies and serves as a superior alternative to plasma exchange. NabGen …
Nami Therapeutics, Inc.
Nami Therapeutics, Inc. is developing XLNT-1, a specifically designed nanoparticle containing the therapeutic radioisotope holmium-166. Intraperetoneal administration may extend survival for cancers such as ovarian, pancreatic, GI and prostrate cancers.
NeuroGT
NeuroGT is focused on development of gene therapy products for treating mucopolysaccharidosis (MPS) disorders and related rare neurogenetic diseases. Founder: Haiyan Fu
New Paradigm Biosciences
New Paradigm Biosciences uses a proprietary humanized mouse platform to develop and test therapeutics. This platform allows the study of human specific pathways and the immune system that other in vivo model systems cannot achieve.
Nuvai Medical Technologies
Nuvai Medical Technologies aims to reduce preventable IV medication errors to make all patient care safer and more efficient. Precynge, a medical device developed by Nuvai Medical Technologies, prevents IV medication errors through highly accurate and precise measurement of medications. Since …
Perotech Corporation
Perotech is developing sensitive X-ray detectors and imaging arrays which are more sensitive, lower cost, compact and easy to use compared to the existing products in the market. Perotech’s X-ray detectors are based on new perovskite materials that enable lower …
Persistence Therapeutics
Persistence Therapeutics is developing a novel cellular immunotherapy platform centered on SynthNode—a biocompatible implant that mimics a synthetic lymph node to generate and deliver potent anti-cancer immune cells directly to tumors. This innovative approach aims to enhance immune system persistence and precision, offering a scalable and effective treatment for solid tumors and other hard-to-treat cancers.
PharmatrophiX
PharmatrophiX is focused on developing small molecule drugs targeting neurotrophin receptors for the treatment of neurodegenerative disorders.
PinPrint
PinPrint is revolutionizing drug delivery through its 3D-printed microneedle patch technology. This platform enables the simple and effective intradermal delivery of vaccines and other active pharmaceutical ingredients. By combining the precision of 3D printing with advanced drug delivery, PinPrint provides a new standard of personalization and comfort for both therapeutic and cosmetic applications.
Polyon Pharmaceutical
Polyon is advancing a patented formulation platform to mitigate and overcome anti-PEG antibodies—immune responses that limit the safety and efficacy of PEGylated therapeutics. Validated in rodent and swine models, Polyon’s molecularly specific approach works immediately, avoids broad immunosuppression, and integrates seamlessly with existing drug manufacturing, offering a scalable solution to extend the lifespan and impact of polymer-modified drugs.
Predictive
Predictive, LLC’s mission is dedicated to using artificial intelligence and machine learning techniques to understand how pharmaceuticals, chemicals, and personal care products affect people. An area we see that has an unmet need is a software platform that can leverage …
Redbud Labs
Redbud Labs manufactures microfluidic components for life science industry. Redbud’s products improve the performance of microfluidic consumables in research, drug discovery, and diagnostics. The core technology is the patented Redbud Posts™, which enable their cartridge-ready components to deliver enhanced microfluidic …
Renovion, Inc.
Renovion is a pre-clinical stage pharmaceutical company with a therapy for chronic inflammatory airway diseases. The company is currently developing Arina-1 as the first FDA-approved therapy for patients who have received a lung transplant and expanding approval into other indications, …
Ribometrix
Ribometrix has developed a proprietary platform for discovering and characterizing the interactions of small molecule drugs that target RNA.
Reveal Genomics
Reveal Genomics is a precision oncology company developing advanced genomic diagnostics to guide cancer treatment decisions. The company offers molecular assays, such as its signature HER2DX test, that provide critical predictive and prognostic insights for different tumor types. This information empowers clinicians to personalize treatment strategies and improve outcomes for cancer patients.
Sandbar Oyster Company
Sandbar developed a novel, biodegradable material – Oyster Catcher™ – that promotes oyster growth and restores/creates estuarine habitats. Sandbar is also bringing innovation and core sustainability to oyster aquaculture by offering forms of Oyster Catcher™ and know-how to produce large …
SonoVascular
SonoVascular is developing a thrombolysis device for the treatment of blood clots related to deep vein thrombosis, pulmonary embolism and peripheral arterial occlusions. The device utilizes an ultrasound transducer that is small enough to be introduced to the blood vessel …
Sorbenta, Inc.
Sorbenta is developing advanced sorbents to remove toxic per- and polyfluoroalkyl substances (PFAS), or “forever chemicals,” from contaminated water sources. Built on platform chemistry licensed from UNC-Chapel Hill, Sorbenta’s patent-protected materials offer superior PFAS selectivity, broad-spectrum removal, and drop-in compatibility with existing water treatment infrastructure, enabling scalable solutions for global water safety challenges.
Syzygy Optics, LLC
Syzygy Optics designs and manufactures affordable, high-performance hyperspectral imaging cameras for applications in agriculture, medical diagnostics, defense, and mining. Leveraging proprietary technologies like curved VPH gratings and spherical transmission grating spectrographs, Syzygy delivers superior image quality, customizable spectral ranges, and cost-effective solutions for precision imaging across industries.
Torque Bio, Inc.
Co-founded by Dr. Aravind Asokan, Torque Bio is pioneering circular mRNA expression systems for gene therapy. Its proprietary platform enables tunable, persistent therapeutic expression, offering a transformative approach to treating genetic diseases with improved durability and precision.
Transchromix LLC
Transchromix is advancing mechanism-based therapeutics for chronic inflammation-associated diseases such as Type 1 diabetes and Alzheimer’s. By leveraging chromatin-activity-based chemoproteomics (ChaC), the company targets noncanonical translation pathways—particularly those regulated by the histone methyltransferase G9a—to modulate disease-driving protein expression with brain-penetrant, precision therapeutics.
Transneural Therapeutics, Inc.
Transneural Therapeutics, Inc. is developing a new class of non-hallucinogenic “neuroplastogens” to treat neuropsychiatric and neurodegenerative disorders. The company’s lead candidates are designed to promote rapid and durable neuroplasticity, replicating the therapeutic benefits of psychedelics without the hallucinogenic side effects. This approach enables broader accessibility and aims to overcome the limitations of current antidepressants.
Triangle Biotechnology
Triangle Biotechnology develops high-throughput, low-cost, user-friendly sonication workflows for biological sample preparation for applications including next-generation sequencing, tissue processing, and cell lysis. Their patented RapidShear® reagents significantly improve the efficiency of sonication-based lysis of biological samples and reduce the energy …
Tripill Biotechnology, Corp.
Tripill Biotechnology specializes in Targeted Radionuclide Therapeutics (TRT) using novel second-generation linkers that enhance pharmacokinetics and on-target activity. Its proprietary platform, including PSMA-targeted agents with reduced salivary gland uptake, aims to improve therapeutic precision and safety in radiopharmaceutical treatment of prostate and other cancers.
VETTA Solutions
VETTA Solutions designs and develops first-in-market devices and applications for detecting, monitoring, and treating conditions that impede healthy human movement. Our inaugural product is a low-cost and clinically-feasible wearable sensor-based system that leverages artificial intelligence and cloud computing for the …